Aka Aktürk Ülkü, Görek Dilektaşlı Aslı, Şengül Aysun, Musaffa Salepçi Banu, Oktay Nuray, Düger Mustafa, Arık Taşyıkan Hale, Durmuş Koçak Nagihan
Clinic of Chest Diseases, Süreyyapaşa Chest Disease and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.
Departmen of Chest Diseases, Uludağ University School of Medicine, Bursa, Turkey.
Balkan Med J. 2017 May 5;34(3):206-211. doi: 10.4274/balkanmedj.2016.1028. Epub 2017 Apr 6.
Influenza and pneumococcal vaccinations are recommended in chronic obstructive pulmonary disease patients to decrease associated risks at all stages. Although the prevalence of chronic obstructive pulmonary disease is high in our country, as previously reported, vaccination rates are low.
To assess the vaccination rates of chronic obstructive pulmonary disease patients and factors that may affect these.
Multi-centre cross-sectional study.
Patients admitted to the chest diseases clinics of six different centres between 1 February 2013 and 1 January 2014 with a pre-diagnosis of Chronic obstructive pulmonary disease according to the Global initiative for chronic obstructive lung disease criteria, who were in a stable condition were included in the study. The survey, which included demographic characteristics, socio-economic status, severity of disease and vaccination information, was first tested on a small patient population before the study. The survey was completed by the investigators after obtaining written informed consent.
The average age of the 296 included patients was 66.3±9.3 years and 91.9% were male. Of these, 36.5% had the influenza vaccination and 14.1% had the pneumococcal vaccination. The most common reason for not being vaccinated was 'no recommendation by doctors': 57.2% in the case of influenza vaccinations, and 46.8% in the case of pneumococcal vaccinations. Both vaccination rates were significantly higher in those patients with comorbidities (influenza vaccination p<0.001; pneumococcal vaccination p=0.06). There was no significant correlation with age, gender, smoking and severity of disease (p>0.05). Vaccination rates were significantly higher in those with a white-collar occupation and higher education level, and who presented to a university hospital (p<0.001).
Medical professionals do not request vaccinations as often as the International Guidelines suggest for chronic obstructive pulmonary disease patients. Awareness of the importance of these vaccinations among both doctors and patients needs to be addressed.
慢性阻塞性肺疾病患者建议接种流感疫苗和肺炎球菌疫苗,以降低各阶段相关风险。尽管我国慢性阻塞性肺疾病患病率较高,但如先前报道,疫苗接种率较低。
评估慢性阻塞性肺疾病患者的疫苗接种率及可能影响接种率的因素。
多中心横断面研究。
2013年2月1日至2014年1月1日期间,根据慢性阻塞性肺疾病全球倡议标准,在六个不同中心的胸科门诊确诊为慢性阻塞性肺疾病且病情稳定的患者纳入研究。在研究前,先在一小部分患者中测试了包括人口统计学特征、社会经济状况、疾病严重程度和疫苗接种信息的调查问卷。在获得书面知情同意后,由研究人员完成调查问卷。
纳入研究 的296例患者平均年龄为66.3±9.3岁,91.9%为男性。其中,36.5%接种了流感疫苗,14.1%接种了肺炎球菌疫苗。未接种疫苗的最常见原因是“医生未建议”:流感疫苗接种者中为57.2%,肺炎球菌疫苗接种者中为46.8%。合并症患者的两种疫苗接种率均显著较高(流感疫苗接种p<0.001;肺炎球菌疫苗接种p=0.06)。与年龄、性别、吸烟和疾病严重程度无显著相关性(p>0.05)。白领职业、高学历且在大学医院就诊的患者疫苗接种率显著较高(p<0.001)。
医疗专业人员对慢性阻塞性肺疾病患者进行疫苗接种的要求未达到国际指南建议的频率。需要提高医生和患者对这些疫苗接种重要性的认识。